U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C19H28N2O2
Molecular Weight 316.4378
Optical Activity UNSPECIFIED
Defined Stereocenters 7 / 7
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of Androstano[2,3-c][1,2,5]oxadiazol-17-ol, (5?,17?)-

SMILES

C[C@]12CC[C@H]3[C@@H](CC[C@H]4CC5=NON=C5C[C@]34C)[C@@H]1CC[C@@H]2O

InChI

InChIKey=QXSGBQLLOLAIIG-VWJMYWFESA-N
InChI=1S/C19H28N2O2/c1-18-8-7-14-12(13(18)5-6-17(18)22)4-3-11-9-15-16(21-23-20-15)10-19(11,14)2/h11-14,17,22H,3-10H2,1-2H3/t11-,12-,13-,14-,17-,18-,19-/m0/s1

HIDE SMILES / InChI

Approval Year

Name Type Language
17?-Hydroxy-5?-androstano[2,3-c]furazan
Preferred Name English
Androstano[2,3-c][1,2,5]oxadiazol-17-ol, (5?,17?)-
Common Name English
[3,2-c]furazan-5?-androstan-17?-ol
Common Name English
Code System Code Type Description
CAS
3662-95-1
Created by admin on Wed Apr 02 19:52:41 GMT 2025 , Edited by admin on Wed Apr 02 19:52:41 GMT 2025
PRIMARY
DEA NO.
4000
Created by admin on Wed Apr 02 19:52:41 GMT 2025 , Edited by admin on Wed Apr 02 19:52:41 GMT 2025
PRIMARY
FDA UNII
EMD57DH62R
Created by admin on Wed Apr 02 19:52:41 GMT 2025 , Edited by admin on Wed Apr 02 19:52:41 GMT 2025
PRIMARY
PUBCHEM
15888232
Created by admin on Wed Apr 02 19:52:41 GMT 2025 , Edited by admin on Wed Apr 02 19:52:41 GMT 2025
PRIMARY